The Wisconsin State Assembly passed AB 840 by a vote of 53-44. The bill sets out several protections for ratepayers, including preventing data center operators from passing their energy costs onto ...

A directive buried in January “minibus” materials is the first step toward carbon taxes or tariffs, several energy policy ...

Senate Democrats just blocked a bill to fund the Department of Homeland Security, after Republicans tried to advance a ...

Georgia Film Academy (GFA) and Assembly Studios are opening a new 32,000-square-foot workforce training facility adjacent to the Assembly Atlanta studio complex in Doraville. Set to open August 18, ...

Tuesday to rescind a January resolution that would have transferred the Shenandoah Valley's dormant 48.5-mile rail corridor, and $35 million in state trail funding, ...

Writing ‘Circle of Days,’ a novel about the construction of Stonehenge, required British author Ken Follett to use his imagination more than he had done for previous novels, since there is no precise ...

Human Rights Watch welcomes the opportunity to offer input for the Special Rapporteur’s upcoming thematic report on curriculum, pedagogy and assessment at the service of the right to education. This ...

Data centers have caused the demand for gas-fired power in the US to explode over the past two years, according to new research released Wednesday. More than a third of this new demand, the research ...

Texas has become a main U.S. test site for small modular nuclear reactors, as leaders hunt for steady power. Researchers estimate that average demand on the Texas grid could nearly ...

GLEN ALLEN, Va., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL ) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies ...

This ruling, and several others like it, reveal a disturbing trend: the Malawian judiciary appears less as an independent arbiter of law and more as a political actor obstructing the legitimate ...

GLEN ALLEN, Va., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) ("Adial" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapies for ...